AZOLYLAMINOAZINE AS INHIBITORS OF PROTEIN KINASES

(19)

(11)

EP 1 485 381 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	12.05.2010 Bulletin 2010/19

(45)	Mention of the grant of the patent:
	17.06.2009 Bulletin 2009/25

(21)	Application number: 03744682.0

(22)	Date of filing: 14.03.2003

(51)

International Patent Classification (IPC):

C07D 417/12^(2006.01)
C07D 487/04^(2006.01)
C07D 413/14^(2006.01)
A61K 31/505^(2006.01)
A61P 31/12^(2006.01)
A61P 9/00^(2006.01)
A61P 19/00^(2006.01)

C07D 471/04^(2006.01)
C07D 413/12^(2006.01)
C07D 417/14^(2006.01)
A61P 37/00^(2006.01)
A61P 35/00^(2006.01)
A61P 7/00^(2006.01)
A61P 3/00^(2006.01)

(86)	International application number:
	PCT/US2003/007904

(87)	International publication number:
	WO 2003/078426 (25.09.2003 Gazette 2003/39)

(54)	AZOLYLAMINOAZINE AS INHIBITORS OF PROTEIN KINASES AZOLYLAMINOAZINE ALS INHIBITOREN VON PROTEINKINASEN AZOLYLAMINOAZINES EN TANT QU'INHIBITEURS DE PROTEINES KINASES

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30)

Priority:

15.03.2002 US 364840 P

(43)	Date of publication of application:
	15.12.2004 Bulletin 2004/51

(73)	Proprietor: VERTEX PHARMACEUTICALS INCORPORATED
	Cambridge, MA 02139 (US)

(72)

Inventors:

BEBBINGTON, David
Newbury Berkshire RG14 1QA (GB)
BINCH, Hayley
Harwell Ocon OX11 0LQ (GB)
CHARRIER, Jean-Damien
Gove Wantage Oxfordshire OX12 7LL (GB)
EVERITT, Simon
Beaconsfield Bucks HP9 2DT (GB)
GOLEC, Julian, M., C.
Ashbury Swindon Wilts SN6 8LS (GB)
KAY, David
Purton Wiltshire SN5 9DR (GB)
KNEGTEL, Ronald
Abingdon Oxon OX14 5NW (GB)
MILLER, Andrew
Upton Oxfordshire OX11 8JL (GB)
PIERARD, Francoise
Drayton Oxfordshire OX14 4LN (GB)

(74)	Representative: Burrichter, Arwed Andreas et al
	COHAUSZ & FLORACK Patent- und Rechtsanwälte Partnerschaftsgesellschaft Bleichstrasse 14 40211 Düsseldorf 40211 Düsseldorf (DE)

(56)

References cited: :

WO-A-01/60816
WO-A-02/50065

WO-A-02/22601
WO-A-02/50066

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).